Rehabilitation for Disuse Atrophy
(MAC Trial)
Trial Summary
What is the purpose of this trial?
This project is a 2-phase, randomized clinical trial that includes 7 days of unilateral leg disuse (Phase 1), immediately followed by 14 days of bilateral leg rehabilitation (Phase 2). The investigators will recruit cohorts of healthy middle-aged men and women to address their aims: * Demonstrate the sex-specific effects of skeletal muscle disuse (Phase 1) * Identify key molecular determinates of susceptibility of skeletal muscle atrophy (Phase 1) * Map the early, sex-specific molecular time-course of rehabilitation (Phase 2) * Determine if disused and healthy muscle respond similarly to exercise (Phase 2) Healthy, middle-age men and post-menopausal women (50-65 years) will be recruited from the greater Houston/Galveston area. This under-represented research demographic demonstrate few negative metabolic or phenotypic signs of advanced age, but are at increased risk of being hospitalized and experiencing accelerated loss of lean mass and muscle function that parallels a much older population. The goal of this study is to characterize phenotypic and molecular skeletal muscle changes in middle-aged men and women during critical periods of disuse and rehabilitation and ultimately direct the development of targeted and effective prevention and treatment strategies.
Do I need to stop my current medications for the trial?
The trial protocol does not specify if you need to stop taking your current medications. However, if you are using systemic steroids, anabolic steroids, growth hormone, or immunosuppressants, you must not have used them within the last 12 months to be eligible.
What data supports the effectiveness of the treatment for Rehabilitation for Disuse Atrophy?
Research shows that resistance training can improve walking speed and balance in older adults, which suggests it may help with disuse atrophy by enhancing strength and independence. Additionally, exercise-based rehabilitation has been effective in improving balance and walking in stroke patients, indicating similar benefits could be expected for disuse atrophy.12345
Is rehabilitation for disuse atrophy generally safe for humans?
Exercise therapies like resistance training and physical therapy are generally safe for humans, but there can be risks, especially for older adults or those with chronic health conditions. It's important to have medical clearance and trained supervision to minimize adverse events (unwanted side effects or injuries).678910
How does this treatment for disuse atrophy differ from other treatments?
This treatment for disuse atrophy is unique because it focuses on resistance exercise, which helps improve muscle strength and size by using different types of exercises like flywheel and isometric exercises. Unlike other treatments, it emphasizes controlling exercise variables such as volume and intensity to effectively remodel and strengthen muscles.1112131415
Research Team
Blake Rasmussen, PhD
Principal Investigator
University of Texas Health Science Center as San Antonio
Eligibility Criteria
Healthy men and women aged 50-65 in the Houston/Galveston area can join this trial. They must be able to consent, speak English, and not have conditions like sarcopenia, severe heart disease, recent eating disorders or significant weight changes. Women should be post-menopausal and men must not have low testosterone levels.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Unilateral Leg Disuse
Participants undergo 7 days of unilateral leg disuse to study the effects of skeletal muscle atrophy
Bilateral Leg Rehabilitation
Participants engage in 14 days of bilateral leg rehabilitation to map the early, sex-specific molecular time-course of recovery
Follow-up
Participants are monitored for safety and effectiveness after rehabilitation
Treatment Details
Interventions
- Resistance Exercise Rehabilitation
- Walking-based rehabilitation
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Medical Branch, Galveston
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Lead Sponsor
National Institute on Aging (NIA)
Collaborator